| 序号 |
标题 |
次数 |
作者 |
发布时间 |
| 83836 |
CAS: 2746391-62-6 MAL-di-EG-Val-Cit-PAB-MMAE |
182 |
zyl |
2024-12-20 |
| 83837 |
2,5-dioxopyrrolidin-1-yl 1-(bicyclo[6.1.0]non-4-yn-9-yl)-3-oxo-2,7,10-trioxa-4-azatridecan-13-oate,ADC定制 |
150 |
kx |
2024-12-20 |
| 83838 |
CAS: 2055041-37-5,Mal-PEG1-Val-Cit-PAB-OH |
172 |
WYQ |
2024-12-20 |
| 83839 |
Cbz-NH-PEG8-CH2COOH |
234 |
h |
2024-12-20 |
| 83840 |
CAS: 2055024-60-5,NH2-PEG6-Val-Cit-PAB-OH |
136 |
WYQ |
2024-12-20 |
| 83841 |
苄基-PEG4-乙酸叔丁酯,cas:1443467-88-6,Benzyl-PEG4-CH2CO2tBu |
151 |
wyh |
2024-12-20 |
| 83842 |
Boc-NH-PEG6-CH2COOH |
163 |
h |
2024-12-20 |
| 83843 |
NEs介导的紫杉醇脂质体药物递送系统(NE-LP-PTX),定制服务 |
202 |
axc |
2024-12-20 |
| 83844 |
perfluorophenyl 3-(2-(2-(2-(cyclooct-2-ynyloxy)acetamido)ethoxy)ethoxy)propanoate,抗体药物偶联物(ADC) |
150 |
kx |
2024-12-20 |
| 83845 |
CAS: 2055024-61-6,NH2-PEG4-Val-Cit-PAB-OH |
149 |
WYQ |
2024-12-20 |
| 83846 |
Azido-PEG7-CH2COOH |
133 |
h |
2024-12-20 |
| 83847 |
mb-vc-MGBA-ADC连接子 |
166 |
zyl |
2024-12-20 |
| 83848 |
Azido-PEG2-CH2COOH |
153 |
h |
2024-12-20 |
| 83849 |
cas:1263044-88-7,2,5-dioxopyrrolidin-1-yl 1-(3-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)phenyl)-1-oxo-5,8,11,14-tetraoxa-2-azaheptadecan-17-oate |
115 |
kx |
2024-12-20 |
| 83850 |
Br-PEG6-CH2COOtBu |
141 |
h |
2024-12-20 |
| 83851 |
白蛋白结合肽修饰的地塞米松脂质体,ABD-Lip/Dex,定制服务 |
141 |
axc |
2024-12-20 |
| 83852 |
Maleimido-mono-amide-DOTA cas:1006711-90-5 |
149 |
zyl |
2024-12-20 |
| 83853 |
2,5-dioxopyrrolidin-1-yl 2-(2-(2-(2-(2,5-dioxo-2H-pyrrol-1(5H)-yl)ethoxy)ethoxy)ethoxy)acetate,ADC定制 |
149 |
kx |
2024-12-20 |
| 83854 |
Tos-PEG3-CH2COOtBu |
161 |
h |
2024-12-20 |
| 83855 |
溶菌酶修饰的百里香精油脂质体,定制服务 |
199 |
axc |
2024-12-20 |
| 83856 |
HO-PEG7-CH2COOH |
198 |
h |
2024-12-20 |
| 83857 |
Mc-vc-PABC-SP 141 -ADC连接子 |
167 |
zyl |
2024-12-20 |
| 83858 |
CAS: 2055024-53-6,Boc-PEG6-Val-Cit-PAB-OH |
194 |
WYQ |
2024-12-20 |
| 83859 |
cas:1252257-56-9,2,5-dioxopyrrolidin-1-yl 3-oxo-1-(pyridin-2-yldisulfanyl)-7,10,13,16,19,22,25,28-octaoxa-4-azahentriacontan-31-oate |
137 |
kx |
2024-12-20 |
| 83860 |
Amino-PEG12-CH2COOH |
129 |
h |
2024-12-20 |
| 83861 |
CAS: 2055024-54-7,Boc-PEG4-Val-Cit-PAB-OH,叔丁酯-四聚乙二醇-VAL-CIT-PAB-羟基 |
134 |
WYQ |
2024-12-20 |
| 83862 |
HO-PEG12-CH2COOH |
127 |
h |
2024-12-20 |
| 83863 |
cas:663599-07-3,1-(4-((5-(dimethylcarbamoyl)pyridin-2-yl)disulfanyl)butanoyloxy)-2,5-dioxopyrrolidine-3-sulfonic acid |
137 |
kx |
2024-12-20 |
| 83864 |
E-选择素结合肽修饰并加载四嗪的膜融合脂质体,EBP-Tz-FLs,定制服务 |
247 |
axc |
2024-12-20 |
| 83865 |
Amino-PEG3-CH2COOH |
143 |
h |
2024-12-20 |
| 83866 |
CAS: 2055024-55-8,Boc-PEG2-Val-Cit-PAB-OH |
215 |
WYQ |
2024-12-20 |
| 83867 |
Tos-PEG4-CH2COOH |
163 |
h |
2024-12-20 |
| 83868 |
cas:663598-85-4,N-succinimidyl 4-(5-nitro-pyridin-2-yldithio)-pentanoate, ADC试剂 |
116 |
kx |
2024-12-20 |
| 83869 |
负载姜黄素的胆碱修饰的脂质体,NP1/Cur,定制服务 |
159 |
axc |
2024-12-20 |
| 83870 |
Boc-NH-PEG4-CH2COOH |
112 |
h |
2024-12-20 |
| 83871 |
CAS: 1951424-92-2,Fmoc-Ala-Ala-Asn(Trt)-OH |
161 |
WYQ |
2024-12-20 |
| 83872 |
CAS:1618096-56-2 Mc-Dexamethasone 抗体-药物偶联物(ADC) |
165 |
zyl |
2024-12-20 |
| 83873 |
CAS: 1639939-40-4,MC-Val-Ala-PAB-PNP |
200 |
WYQ |
2024-12-20 |
| 83874 |
Fmoc-NH-PEG4-CH2COOH |
131 |
h |
2024-12-20 |
| 83875 |
perfluorophenyl 3-(2-(2-(1,3-dioxoisoindolin-2-yloxy)ethoxy)ethoxy)propanoate,ADC定制 |
139 |
kx |
2024-12-20 |
| 83876 |
CAS: 1870916-87-2,MC-Val-Ala-PAB,6-(2,5-二氧代-2,5-二氢-1H-吡咯-1-基)-N-((S)-1-(((S)-1-((4-(羟甲基)苯基)氨基)-1-氧代丙烷-2-基)氨基)-3-甲基-1-氧代丁-2-基)己酰胺 |
128 |
WYQ |
2024-12-20 |
| 83877 |
Amino-PEG4-CH2COOH |
152 |
h |
2024-12-20 |
| 83878 |
CAS号1473403-87-0 MC-SN38 抗体-药物偶联物(ADC) |
199 |
zyl |
2024-12-20 |
| 83879 |
Alkyne-Val-Cit-PAB-PNP(CAS号:2748039-77-0) |
137 |
WYQ |
2024-12-20 |
| 83880 |
Fmoc-NH-PEG4-CH2CH2COOH |
169 |
h |
2024-12-20 |